Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prophylactic platelet transfusion.

Wandt H, Schäfer-Eckart K, Ehninger G.

N Engl J Med. 2013 Aug 8;369(6):577. doi: 10.1056/NEJMc1307163. No abstract available.

PMID:
23924012
2.

Prophylactic platelet transfusion.

Slichter SJ.

N Engl J Med. 2013 Aug 8;369(6):577-8. doi: 10.1056/NEJMc1307163. No abstract available.

3.

Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.

Schiffer CA.

Nat Rev Clin Oncol. 2013 Aug;10(8):431-2. doi: 10.1038/nrclinonc.2013.113. Epub 2013 Jul 2. No abstract available.

PMID:
23820637
4.

Eliminate prophylactic platelet transfusions?

Slichter SJ.

N Engl J Med. 2013 May 9;368(19):1837-8. doi: 10.1056/NEJMe1302974. No abstract available.

PMID:
23656650
5.

[Thrombocytopenia: is therapeutic platelet transfusion effective? Prophylactic platelet transfusion remains justified].

Bethge W.

Dtsch Med Wochenschr. 2012 Dec;137(50):2630. doi: 10.1055/s-0032-1329030. Epub 2012 Dec 5. German. No abstract available.

PMID:
23225185
6.

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.

Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Mahlknecht U, Ho A, Schaich M, Kramer M, Kaufmann M, Leimer L, Schwerdtfeger R, Conradi R, Dölken G, Klenner A, Hänel M, Herbst R, Junghanss C, Ehninger G; Study Alliance Leukemia.

Lancet. 2012 Oct 13;380(9850):1309-16. doi: 10.1016/S0140-6736(12)60689-8. Epub 2012 Aug 8.

PMID:
22877506
7.

Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?

Stanworth SJ, Hyde C, Brunskill S, Murphy MF.

Br J Haematol. 2005 Dec;131(5):588-95. Review.

PMID:
16351634
8.

Therapeutic platelet transfusion for hypoproliferative thrombocytopenia.

Takahashi Y, Nishikawa Y, Mori J, Hamaki T, Tanimoto T.

Lancet. 2013 Mar 2;381(9868):724. doi: 10.1016/S0140-6736(13)60577-2. No abstract available.

PMID:
23472915
9.

Therapeutic platelet transfusion for hypoproliferative thrombocytopenia.

Tsuda K, Morita T, Tsubokura M, Matsumura T, Kami M.

Lancet. 2013 Mar 2;381(9868):723-4. doi: 10.1016/S0140-6736(13)60576-0. No abstract available.

PMID:
23472914
10.

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF.

Cochrane Database Syst Rev. 2015 Oct 27;(10):CD010984. doi: 10.1002/14651858.CD010984.pub2. Review.

11.

Therapeutic platelet transfusion for hypoproliferative thrombocytopenia - authors' reply.

Wandt H, Schaefer-Eckart K.

Lancet. 2013 Mar 2;381(9868):724. doi: 10.1016/S0140-6736(13)60578-4. No abstract available.

PMID:
23472916
12.

Platelet transfusion strategy for hematologic cancers.

Podda GM, Ricci S.

Intern Emerg Med. 2015 Feb;10(1):81-2. doi: 10.1007/s11739-014-1148-6. Epub 2014 Oct 31. No abstract available.

PMID:
25358897
13.

A no-prophylaxis platelet-transfusion strategy for hematologic cancers.

Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, Norfolk D, Copplestone A, Smith N, Kerr P, Jones G, Raj K, Westerman DA, Szer J, Jackson N, Bardy PG, Plews D, Lyons S, Bielby L, Wood EM, Murphy MF; TOPPS Investigators.

N Engl J Med. 2013 May 9;368(19):1771-80. doi: 10.1056/NEJMoa1212772.

14.

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.

Stanworth SJ, Dyer C, Choo L, Bakrania L, Copplestone A, Llewelyn C, Norfolk D, Powter G, Littlewood T, Wood EM, Murphy MF; TOPPS Study Group.

Transfus Med Rev. 2010 Jul;24(3):163-71. doi: 10.1016/j.tmrv.2009.11.002. Review.

PMID:
20656185
15.

Real-time ultrasound-guided central venous catheterization reduces the need for prophylactic platelet transfusion in thrombocytopenic patients with hematological malignancy.

Tomoyose T, Ohama M, Yamanoha A, Masuzaki H, Okudaira T, Tokumine J.

Transfus Apher Sci. 2013 Oct;49(2):367-9. doi: 10.1016/j.transci.2012.09.005. Epub 2012 Oct 18. No abstract available.

PMID:
23083962
16.

Compliance with prophylactic platelet transfusion trigger in haematological patients.

Eikenboom JC, van Wordragen R, Brand A.

Transfus Med. 2005 Feb;15(1):45-8.

PMID:
15713128
17.

Thrombocytopenia and platelet transfusions in patients with cancer.

Valent J, Schiffer CA.

Cancer Treat Res. 2011;157:251-65. doi: 10.1007/978-1-4419-7073-2_15. Review.

PMID:
21052961
18.

Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.

Crighton GL, Estcourt LJ, Wood EM, Stanworth SJ.

Hematol Oncol Clin North Am. 2016 Jun;30(3):541-60. doi: 10.1016/j.hoc.2016.01.002. Review.

PMID:
27112995
19.

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.

Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell S, Stanworth SJ, Murphy MF.

Cochrane Database Syst Rev. 2016 Aug 22;(8):CD010982. doi: 10.1002/14651858.CD010982.pub2. Review.

20.

Prophylactic platelet transfusions.

Estcourt LJ, Stanworth SJ, Murphy MF.

Curr Opin Hematol. 2010 Sep;17(5):411-7. doi: 10.1097/MOH.0b013e32833c07e8. Review.

PMID:
20601869

Supplemental Content

Support Center